We found that the melanoma cells were indeed protected against BRAF and MEK inhibition (Fig. 6 G), although protection was lost if macrophage-conditioned medium was preincubated with IL-1β–neutralizing antibody or IL-1 receptor antagonist (IL-1RA; Fig. 6 G), further confirming a role for macrophage secretion of IL-1β in protecting melanoma cells against MAPK inhibitors. Here, MAP2K7 is linked to melanoma.